Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 15, 2018

DrugPatentWatch Database Preview

Actavis Totowa Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS TOTOWA, and what generic and branded alternatives to ACTAVIS TOTOWA drugs are available?

ACTAVIS TOTOWA has twenty-two approved drugs.

Summary for Actavis Totowa

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	22
Patent Litigation for Actavis Totowa:	See patent lawsuits for Actavis Totowa

Drugs and US Patents for Actavis Totowa

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Totowa	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071766-001	Oct 5, 1987	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	EPIRUBICIN HYDROCHLORIDE	epirubicin hydrochloride	INJECTABLE;INJECTION	065445-003	Sep 18, 2008	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	TOPIRAMATE	topiramate	TABLET;ORAL	078637-004	Feb 27, 2013		DISCN	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	CARBOPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	078732-001	Feb 6, 2012		DISCN	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	REPAGLINIDE	repaglinide	TABLET;ORAL	090008-003	Jan 22, 2014	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	CARBOPLATIN	carboplatin	INJECTABLE;IV (INFUSION)	078732-003	Feb 6, 2012		DISCN	No	No		➤ Sign Up				➤ Sign Up
Actavis Totowa	OXALIPLATIN	oxaliplatin	INJECTABLE;IV (INFUSION)	078803-001	Aug 8, 2012	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji

Boehringer Ingelheim

QuintilesIMS

AstraZeneca

Covington

UBS

Harvard Business School

Mallinckrodt

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.